Tenax Therapeutics, Inc.
Clinical trials sponsored by Tenax Therapeutics, Inc., explained in plain language.
A specialty pharmaceutical company developing treatments for cardiovascular and pulmonary diseases.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New pill could help heart failure patients breathe easier and walk farther
Disease control OngoingThis study tests an oral medication called levosimendan in people who have both pulmonary hypertension (high blood pressure in the lungs) and a type of heart failure where the heart pumps normally but is stiff. The goal is to see if the drug helps them walk farther in 6 minutes c…
Phase: PHASE3 • Sponsor: Tenax Therapeutics, Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Heart failure patients get continued access to promising oral treatment
Disease control ENROLLING_BY_INVITATIONThis study offers continued access to an oral medication called levosimendan for people with pulmonary hypertension (high blood pressure in the lungs) and a type of heart failure where the heart pumps normally but is stiff. About 800 participants who completed a previous levosime…
Phase: PHASE3 • Sponsor: Tenax Therapeutics, Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC